title: Tumor necrosis factor (TNF) enhances the locomotion of low-density human tonsillar B lymphocytes through the selective triggering of type II receptor.
authors.affiliation: Laboratory of Oncology, Scientific Institute G. Gaslini, Genova, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Corcione
authors.forename: L
authors.initials: L
authors.lastname: Ottonello
authors.forename: G
authors.initials: G
authors.lastname: Tortolina
authors.forename: P
authors.initials: P
authors.lastname: Tasso
authors.forename: F
authors.initials: F
authors.lastname: Ghiotto
authors.forename: I
authors.initials: I
authors.lastname: Airoldi
authors.forename: R
authors.initials: R
authors.lastname: D'Agostino
authors.forename: F
authors.initials: F
authors.lastname: Dallegri
authors.forename: V
authors.initials: V
authors.lastname: Pistoia
mesh_terms: D000251:Adenosine Triphosphatases; D015703:Antigens, CD / Q000378:metabolism; D001081:Apyrase; D001402:B-Lymphocytes / Q000166:cytology*; D002465:Cell Movement / Q000187:drug effects*; D005434:Flow Cytometry; D006801:Humans; D007072:Immunoglobulin D / Q000378:metabolism; D014066:Palatine Tonsil / Q000166:cytology*; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: D015703:Antigens, CD; D007072:Immunoglobulin D; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000251:Adenosine Triphosphatases; D001081:Apyrase; C067869:CD39 antigen